article thumbnail

Top 14 BioPharmaceutical Consultants & Consulting Firms

Jake Jorgovan

The Value of a Biopharma Consulting Firm Beyond mere compliance, these consultants offer strategic vision. BioPharma Consultants : Specializes in marketing, strategy, and corporate development services for the biotech and pharmaceutical industries, offering solutions from product launch plans to commercial support for fundraising.

article thumbnail

Top Drug Discovery Consulting Firms, Companies, Services, & Consultants

Jake Jorgovan

BCG Biopharma : BCG Biopharma helps companies innovate and bring new medicines to market quickly by utilizing digital tools, data, and advanced analytics across R&D, commercial models, operations, and corporate finance.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Drug Development Consulting Firms, Companies, Services, & Consultants

Jake Jorgovan

Boston Consulting Group (BCG) Boston Consulting Group (BCG) provides strategic consulting services to biopharma companies, helping them leverage new technologies, digital transformation, and advanced analytics to accelerate innovation and bring new medicines to market more efficiently.

Biopharma 130
article thumbnail

Top 11 Life Science Consultants & Consulting Firms

Jake Jorgovan

CSSi LifeSciences empowers companies and innovators from discovery to commercialization, with an integrated model that delivers value-creation for early-stage and emerging growth companies. The company provides customized solutions to mitigate risks, time, and expenses, supporting U.S. market goals for its clients.

article thumbnail

Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?

LaVoie Health Science Blog

Given the number of public companies – including many blue-chip pharma and biopharma large caps – that have seen their stock prices swing wildly, from this strict valuation perspective alone, the current environment seems as if it should present a historic opportunity to activist investors.

Biotech 52
article thumbnail

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

What are some of the unique considerations that biopharma and life science firms must consider in mapping out their ESG strategies? Certainly few industries have received more scrutiny over the past year than biopharma. Enough said.